Clarithromycin Actavis

Medicinal product

(Invented) name

Clarithromycin Actavis

Active substance (s)

Klaritromicinas

Strength

500 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01FA09, Clarithromycin

Marketing authorisation holder

Actavis Group PTC ehf., Islandija

Date of authorisation

2012-01-27

Date of renewal

2015-12-10

Documents

2784_1_4 Clarithromycin Actavis PCS PL 160630.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/0432/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Klaritromicinas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
43026	56795	1056795	lizdinė plokštelė	N6		Receptinis	LT/1/12/2784/001	Netiekiama	-	-	No	-	-
50884	64774	1064774	lizdinė plokštelė	N7		Receptinis	LT/1/12/2784/002	Netiekiama	-	-	No	-	-
50885	64775	1064775	lizdinė plokštelė	N10		Receptinis	LT/1/12/2784/003	Netiekiama	-	-	No	-	-
50886	64776	1064776	lizdinė plokštelė	N14		Receptinis	LT/1/12/2784/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-12-05	Išregistruotas
2015-12-10	Perregistruotas
2012-01-27	Registruotas